JW Pharmaceutical Corp (001060):企業の財務・戦略的SWOT分析

◆英語タイトル:JW Pharmaceutical Corp (001060) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15130
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
JW Pharmaceutical Corp (JW Pharmaceutical), a subsidiary of JW Holdings Corp is a provider of generic drugs. The company develops and markets analgesics, antipyretics and cold remedy, antidote agents, antimicrobials, anticancer agents, and others. It offers multivitamins and antianemic agents, contact lens care and ophthalmic agents, antifungal agents, cardiovascular agents, and gastrointestinla agents. JW Pharmaceutical also offers topicals, amino acid solutions, flexible IV container, IV solutions, respiratory agents, obgy agents, nephrology agents, CNS, urology agents and diabetic agents. The company offers products for cardiovascular, gastrointestinal, nephrology or antianaemic, anticancer and neuropsychiatry. It operates through its production and manufacturing facilities in South Korea. JW Pharmaceutical is headquartered in Seoul, South Korea.

JW Pharmaceutical Corp Key Recent Developments

Oct 29,2018: JW Pharmaceutical invests in British anti-cancer drugs developer
Aug 28,2018: LEO Pharma to develop and commercialise JW Pharmaceutical’s JW1601

This comprehensive SWOT profile of JW Pharmaceutical Corp provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of JW Pharmaceutical Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

JW Pharmaceutical Corp – Key Information
JW Pharmaceutical Corp – Overview
JW Pharmaceutical Corp – Key Employees
JW Pharmaceutical Corp – Key Employee Biographies
JW Pharmaceutical Corp – Key Operational Heads
JW Pharmaceutical Corp – Major Products and Services
JW Pharmaceutical Corp – History
JW Pharmaceutical Corp – Company Statement
JW Pharmaceutical Corp – Locations And Subsidiaries
JW Pharmaceutical Corp – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

JW Pharmaceutical Corp – Business Description
JW Pharmaceutical Corp – Corporate Strategy
JW Pharmaceutical Corp – SWOT Analysis
SWOT Analysis – Overview
JW Pharmaceutical Corp – Strengths
JW Pharmaceutical Corp – Weaknesses
JW Pharmaceutical Corp – Opportunities
JW Pharmaceutical Corp – Threats
JW Pharmaceutical Corp – Key Competitors

Section 3 – Company Financial Performance Charts

JW Pharmaceutical Corp – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

JW Pharmaceutical Corp, Key Information
JW Pharmaceutical Corp, Key Ratios
JW Pharmaceutical Corp, Share Data
JW Pharmaceutical Corp, Major Products and Services
JW Pharmaceutical Corp, History
JW Pharmaceutical Corp, Key Employees
JW Pharmaceutical Corp, Key Employee Biographies
JW Pharmaceutical Corp, Key Operational Heads
JW Pharmaceutical Corp, Other Locations
JW Pharmaceutical Corp, Subsidiaries
JW Pharmaceutical Corp, Key Manufacturing facilities
JW Pharmaceutical Corp, Key Competitors
JW Pharmaceutical Corp, SWOT Analysis
JW Pharmaceutical Corp, Ratios based on current share price
JW Pharmaceutical Corp, Annual Ratios
JW Pharmaceutical Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

JW Pharmaceutical Corp, Performance Chart
JW Pharmaceutical Corp, Ratio Charts

★海外企業調査レポート[JW Pharmaceutical Corp (001060):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oil & Gas Development Co Ltd (OGDC):石油・ガス:M&Aディール及び事業提携情報
    Summary Oil & Gas Development Co Ltd (OGDCL) is an integrated upstream oil and gas company. It explores, develops and produces oil and gas from its assets in the provinces of Punjab, Sindh, Balochistan, and Kyber Pakhtoon Khawa (KPK) in Pakistan. OGDCL owns interests in operated and non-operated exp …
  • Bionomics Ltd (BNO):企業の財務・戦略的SWOT分析
    Summary Bionomics Ltd (Bionomics) is a biopharmaceutical company that discovers and develops treatments for cancer, and central nervous system disorders such as anxiety, depression and Alzheimer's disease. The company provides pipeline products such as BNC210, BNC 105, BNC101 and BNC375, among other …
  • Osaka University-製薬・医療分野:企業M&A・提携分析
    Summary Osaka University (OU) is an educational university that offers undergraduate and graduate courses. The university offers courses in dentistry, economics, engineering, engineering science, foreign studies, human sciences, law and politics, medicine, information science and technology, languag …
  • Kane Biotech Inc (KNE):企業の財務・戦略的SWOT分析
    Summary Kane Biotech Inc (Kane Biotech) is a biotechnology company which focuses on research, development and commercialization of novel products that prevent and remove biofilm related infections in humans and animals. The company’s products include StrixNB and Vetradent water additive, oral spray, …
  • Idexx Laboratories Inc (IDXX)-製薬・医療分野:企業M&A・提携分析
    Summary Idexx Laboratories Inc (IDEXX) is a diagnostics company. It develops, manufactures and distributes products and services for small animals and livestock. The company offers veterinary reference laboratory diagnostics and consulting services, point-of-care veterinary diagnostic products, micr …
  • Zafgen Inc (ZFGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Zafgen Inc (Zafgen) is a clinical-stage biopharmaceutical company that develops transformative therapies for patients affected by a range of metabolic diseases. Its pipeline product portfolio includes ZGN-1061, a small molecule MetAP2 inhibitor being developed for patients with type 2 diabet …
  • Ricoh India Ltd:企業の戦略的SWOT分析
    Ricoh India Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Connected Energy:企業の戦略的SWOT分析
    Connected Energy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Nomura Holdings, Inc.:企業の戦略・SWOT・財務情報
    Nomura Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nomura Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Exfo Inc.:企業の戦略・SWOT・財務分析
    Exfo Inc. - Strategy, SWOT and Corporate Finance Report Summary Exfo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Superior Energy Services Inc (SPN):企業の財務・戦略的SWOT分析
    Superior Energy Services Inc (SPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Bioceptive Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bioceptive Inc (Bioceptive) is a medical device company that provides medical devices for a variety of gynaecological procedures. The company offers products such as intrauterine devices, intuitive IUD insertion systems and IUD inserters, among others. Its intrauterine devices offer less tra …
  • Tata Communications Limited:企業の戦略・SWOT・財務分析
    Tata Communications Limited - Strategy, SWOT and Corporate Finance Report Summary Tata Communications Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • CalAmp Corp. (CAMP):企業の財務・戦略的SWOT分析
    CalAmp Corp. (CAMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Blue Sky Uranium Corp. (BSK):企業の財務・戦略的SWOT分析
    Blue Sky Uranium Corp. (BSK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Carestream Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary Carestream Health Inc (Carestream) a subsidiary of Onex Corp, provides dental and medical imaging systems and healthcare IT solutions. It also offers X-ray film and digital X-ray systems for non-destructive testing; and advanced materials for the precision films and electronics markets. Care …
  • Energy Resources Conservation and Development Commission:企業の戦略的SWOT分析
    Energy Resources Conservation and Development Commission - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key …
  • Redx Pharma Plc (REDX):企業の財務・戦略的SWOT分析
    Summary Redx Pharma Plc (Redx Pharma), formerly Redx Pharma Ltd is a drug discovery and development company that develops early stage and small molecule therapeutics. The company’s pipeline products include inhibitors for oncology and anti-infectives for treatment of diseases that include influenza …
  • Pier 1 Imports, Inc.:戦略・SWOT・企業財務分析
    Pier 1 Imports, Inc. - Strategy, SWOT and Corporate Finance Report Summary Pier 1 Imports, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Roper Technologies Inc (ROP):企業の財務・戦略的SWOT分析
    Roper Technologies Inc (ROP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆